Perinatal Outcomes in Obese Women with One Abnormal Value on 3-Hour Oral Glucose Tolerance Test
Authors:
- Victoria R. GreenbergVGVictoria R. Greenberg
- Lisbet S. LundsbergLLLisbet S. Lundsberg
- Uma M. ReddyURUma M. Reddy
- William A. GrobmanWGWilliam A. Grobman
- Corette B. ParkerCPCorette B. Parker
- Samuel ParrySPSamuel Parry
- Rebecca J. PostRPRebecca J. Post
- Anthony L. ShanksASAnthony L. Shanks
- Robert M. SilverRSRobert M. Silver
- Hyagriv SimhanHSHyagriv Simhan
- Ronald J. WapnerRWRonald J. Wapner
- Audrey A. MerriamAMAudrey A. Merriam
- 31 December 2021
- journal article
- research article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 39 (05) , 464-472
Abstract
Objective This study aimed to determine if one abnormal value of four on the diagnostic 3-hour oral glucose tolerance test (OGTT) is associated with adverse perinatal outcomes in obese women. Study Design This is a secondary analysis of a prospective study of nulliparous women in eight geographic regions. Women with body mass index 2 and pregestational diabetes mellitus (GDM) were excluded. Four groups were compared: (1) normal 50-g 1-hour glucose screen, (2) elevated 1-hour glucose screen with normal 100-g 3-hour diagnostic OGTT, (3) elevated 1-hour glucose screen and one of four abnormal values on 3-hour OGTT, and (4) GDM. Using multivariable logistic regression adjusting for covariates, the women in the groups with dysglycemia were compared with those in the normal screen group for maternal and neonatal outcomes. Results Among 1,713 obese women, 1,418 (82.8%) had a normal 1-hour glucose screen, 125 (7.3%) had a normal 3-hour diagnostic OGTT, 72 (4.2%) had one abnormal value on their diagnostic OGTT, and 98 (5.7%) were diagnosed with GDM. The one abnormal value group had increased risk of large for gestational age (LGA) neonates (adjusted odds ratio [aOR] = 2.24, 95% confidence interval [CI]: 1.31–3.82), cesarean delivery (aOR = 2.19, 95% CI: 1.34–3.58), and hypertensive disorders of pregnancy (aOR = 2.19, 95% CI: 1.32–3.63) compared with normal screens. The one abnormal value group also had an increased risk of preterm birth <37 weeks (aOR = 2.63, 95% CI: 1.43–4.84), neonatal respiratory support (aOR = 2.38, 95% CI: 1.23–4.60), and neonatal hyperbilirubinemia (aOR = 2.00, 95% CI: 1.08–3.71). There was no association between one abnormal value with shoulder dystocia and neonatal hypoglycemia. Conclusion For obese women, one abnormal value on the 3-hour OGTT confers increased perinatal adverse outcomes. These women should be studied further to determine if nutrition counseling and closer fetal monitoring improve outcomes even in the absence of a diagnosis of GDM. Key Points Received: 14 November 2020 Accepted: 04 October 2021 Publication Date: 31 December 2021 (online) © 2021. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAKeywords
This publication has 24 references indexed in Scilit:
- A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b)American Journal of Obstetrics and Gynecology, 2015
- Gestational diabetes mellitus: risks and management during and after pregnancyNature Reviews Endocrinology, 2012
- Maternal Body Mass Index Is a Predictor of Neonatal Hypoglycemia in Gestational Diabetes MellitusThe Journal of Clinical Endocrinology & Metabolism, 2012
- A Multicenter, Randomized Trial of Treatment for Mild Gestational DiabetesNew England Journal of Medicine, 2009
- Hyperglycemia and Adverse Pregnancy OutcomesNew England Journal of Medicine, 2008
- Impact of maternal body mass index on neonate birthweight and body compositionAmerican Journal of Obstetrics and Gynecology, 2008
- Normal Glucose Tolerance and Gestational Diabetes MellitusDiabetes Care, 2007
- The influence of obesity and diabetes on the prevalence of macrosomiaAmerican Journal of Obstetrics and Gynecology, 2004
- Gestational Diabetes MellitusDiabetes Care, 2002
- Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancyAmerican Journal of Obstetrics and Gynecology, 1989